HBV Alliance: Program Overview

Target Audience:

This program is designed to meet the educational needs of community-based healthcare providers at Federally Qualified Health Centers (FQHCs) and community health centers who are involved in the diagnosis and management of patients

with HBV.


The HBV Alliance will focus on advancing HBV management and therapeutics knowledge by establishing a platform and forum for health care professionals to experience high-quality education delivered by leading experts in the field.

Educational objectives:

Upon completion of this activity, participants should be able to:

  • Review data on the prevalence and transmission of HBV

  • Define the risk of HBV among different patient populations, highlighting high-risk settings

  • Describe the detrimental effects of untreated, chronic HBV to emphasize the need for diagnosis and treatment

  • Demonstrate strategies to incorporate various diagnostic and treatment guidelines into clinical practice

  • Analyze approved and emerging treatment options for HBV

  • Identify patients that are likely to benefit from emerging treatment options versus currently available therapies

overview graphic.png

The ECHO model™ breaks down the walls between specialty and primary care. It links expert specialist teams at an academic ‘hub’ with primary care clinicians in local communities — the ‘spokes’ of the model. Essentially, ECHO® creates ongoing learning communities where primary care clinicians receive support and develop the skills they need to treat a particular condition. As a result, they can provide comprehensive, best-practice care to patients with complex health conditions, right where they live.

Accredited by

Rehoboth Logo.png

Provided by

This program is supported by an educational grant from Gilead Sciences.